CYPH - Cytoclonal Pharmaceutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics

CYPH 2.270

-22.8%

Nov 21 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sir Auric Goldfinger who wrote (220)	7/1/1998 8:51:00 PM
From: SPEEDRACER	Read Replies (1) of 428

You seem very sure of yourself in bad mouthing CYPH. As I understand it, they will get 50 million from BMY over the next 2 to 3 years, that's an average of 1$ a share per year for the first three, then they will get in excess of 10 million a year from royalties. That's just from BMY!!!!!! Also BMY can only use CYPH's taxol for certain cancers. CYPH is talking to many other companies and will certainly come up with many more agreements that will be revenue producing. The 10 Million a year after the first three is about 75 cents a share. At 10$ this would be a fair price if that was the end of it. However the potential revenues from all other deals that CYPH can put together clearly puts this stock at a serious undervaluation. I bought more today . I averaged buying 10k at 6.75 sold 5k at the close today and kept the rest. What a gift...... SPEEDY==========================

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next